According to the GSEA analysis, the high-risk group was mainly associated with the Notch, VEGF, WNT, MAPK, and TGF-β signaling pathways, which are tumor-related pathways (Figure 6A; Table 3). The gene discussed is TGFB1; the disease is neoplasm.